» Authors » P D Soldato

P D Soldato

Explore the profile of P D Soldato including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 5
Citations 61
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Wedel S, Sparatore A, Soldato P, Al-Batran S, Atmaca A, Juengel E, et al.
J Cell Mol Med . 2008 Feb; 12(6A):2457-66. PMID: 18266964
The anti-epileptic drug valproic acid is also under trial as an anti-cancer agent due to its histone deacetylase (HDAC) inhibitory properties. However, the effects of valproic acid (VPA) are limited...
2.
Minuz P, Degan M, Gaino S, Meneguzzi A, Zuliani V, Santonastaso C, et al.
Br J Pharmacol . 2001 Oct; 134(4):905-11. PMID: 11606332
NCX4016 (2 acetoxy-benzoate 2-(2-nitroxymethyl)-phenyl ester, NicOx S.A., France) is an anti-thrombotic agent, chemically related to acetylsalicylic acid (ASA) and able to release NO. We tested the effects of NCX4016 and...
3.
Fiorucci S, Santucci L, Cirino G, Mencarelli A, Familiari L, Soldato P, et al.
J Immunol . 2000 Oct; 165(9):5245-54. PMID: 11046058
Caspase-1, the IL-1beta converting enzyme (ICE), is required for intracellular processing/maturation of IL-1beta and IL-18. NO releasing nonsteroidal antiinflammatory drugs (NSAIDs) are a new class of NSAID derivatives that spare...
4.
Fiorucci S, Santucci L, Federici B, Antonelli E, Distrutti E, Morelli O, et al.
Aliment Pharmacol Ther . 1999 Apr; 13(3):421-35. PMID: 10102977
Background: Nitric oxide (NO)-releasing NSAIDs are a new class of NSAID derivatives with markedly reduced gastrointestinal toxicity. Although it has been demonstrated that NO-NSAIDs spare gastric mucosal blood flow, molecular...
5.